Martin Reck, Head of Department at LungenClinic Grosshansdorf, shared on LinkedIn by ETOP IBCSG Partners Foundation, adding:
“A fantastic, interactive update on this exciting, fast-moving field in Oncology. Grateful for the invitation and for meeting so many dear colleagues from all over the world.
Thank you, ETOP IBCSG Partners Foundation, for hosting this exceptional meeting!
Quoting ETOP IBCSG Partners Foundation:
“An amazing group of experts gathering at our 2nd T-cell engager workshop in Zurich discussing current clinical data focusing on the clinical management of adverse events as well as the shift to ambulatory management.
Also, developments in the field and TR questions were presented.”

You can also read ‘Outpatient Bispecific Antibodies: Considerations for Step-Up Dosing, CRS, and ICANS”
